CVE-2015-3954

highpriority · track · 40EPSS 0.020 · 81 %ileEUUS
grimoire priorityP2 · Scheduled
Exploitable?
—
no known exploitation
Likely / severe?
2.04% (81st) EPSS
CVSS 10 · high
Is it mine?
12 products
Check your exposure
Who says so?
4 sources
cnnvd · enisa_euvd · cisa_csaf_ot · nvd

EPSS · scored 2026-10-27

Hospira Plum A+ Infusion System version 13.4 and prior, Plum A+3 Infusion System version 13.6 and prior, and Symbiq Infusion System, version 3.13 and prior give unauthenticated users root privileges on Port 23/TELNET by default. An unauthorized user could issue commands to the pump. Hospira recommends that customers close Port 23/TELNET on the affected devices. Hospira has also released the Plum 360 Infusion System which is not vulnerable to this issue.

01

remediations

Vendor fix, mitigation, or workaround guidance, as published by each source.

No vendor fix yet; a mitigation is available.

  • MitigationPlum A+ Infusion Systemcisa_csaf_ot

    For additional information about the vulnerabilities and compensating measures, contact Hospira’s technical support at 1-800-241-4002.

  • MitigationPlum A+3 Infusion Systemcisa_csaf_ot

    For additional information about the vulnerabilities and compensating measures, contact Hospira’s technical support at 1-800-241-4002.

  • MitigationSymbiq Infusion System,As previously announced by Hospira in 2013, the Symbiq Infusion System was retired by Hospira on May 31, 2015 and will be fully removed from the market by December 2015. According to Hospira, during a recent service visit, the remaining Symbiq Infusion Systems have had Port 20/FTP and Port 23/TELNET closedcisa_csaf_ot

    For additional information about the vulnerabilities and compensating measures, contact Hospira’s technical support at 1-800-241-4002.

02

cvss

Technical severity, 0–10. One row per scoring source.

10.0
010

base score 0–10 · higher = more severe · hover a vector to decode⚠ sources disagree · high–critical · 9–10

v2.010highAV:N/AC:L/Au:N/C:C/I:C/A:Cprimary · NVD / NIST USexploitability 10 · impact 10
v3.09.8criticalCVSS:3.0/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:Hprimary · NVD / NIST USexploitability 3.9 · impact 5.9
v2.010criticalAV:N/AC:L/Au:N/C:C/I:C/A:Csecondary · CISA US
v3.09criticalCVSS:3.0/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H/E:Usecondary · CVSS-BT (t0sche)
03

weaknesses

The CWE weakness classes this flaw belongs to.

04

affected products (12)

Products and version ranges known to be affected.

05

advisories (1)

Vendor and ecosystem advisories describing this.

  • ICSA-15-161-01Hospira Plum A+ and Symbiq Infusion Systems Vulnerabilities2015-03-13icsa · cisa_csaf_otUS

    This CSAF advisory was extracted from unstructured data and may contain inaccuracies. If you notice any errors, please reach out to the designated contact at CISA CSAF: central@cisa.dhs.gov

06

also known as (3)

Other names and identifiers for this entity.

07

sources

Which sources assert this record, and when.

published 2019-03-25modified 2026-06-17
09

references (4)

External citations — patches, advisories, analysis.

scry

Attackers weaponise vulnerabilities like this against internet-exposed services. See what is exposed on your perimeter with a free passive scan.

Free scan